Compounds > 4-iodo-2,5-dimethoxyphenylisopropylamine
Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Infarction, Middle Cerebral Artery

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Infarction, Middle Cerebral Artery in 1 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.

Research Excerpts

ExcerptRelevanceReference
"The effect of ST1942, a 2-aminotetraline derivative with anti-inflammatory properties, was evaluated in ischemia/reperfusion injury in CD1 and C57BL/6 mice."3.742-Aminotetraline derivative protects from ischemia/reperfusion brain injury with a broad therapeutic window. ( Capone, C; Carminati, P; De Simoni, MG; Fabrizi, C; Fumagalli, L; Ghirardi, O; Marzorati, P; Piovesan, P; Principato, MC, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capone, C1
Fabrizi, C1
Piovesan, P1
Principato, MC1
Marzorati, P1
Ghirardi, O1
Fumagalli, L1
Carminati, P1
De Simoni, MG1

Other Studies

1 other study available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Infarction, Middle Cerebral Artery

ArticleYear
2-Aminotetraline derivative protects from ischemia/reperfusion brain injury with a broad therapeutic window.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:6

    Topics: Amphetamines; Animals; Behavior, Animal; Brain Diseases; Cerebrovascular Circulation; CHO Cells; Cri

2007